Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography at 3.0-T: A Multicenter Trial
NCT ID: NCT01024478
Last Updated: 2011-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
272 participants
OBSERVATIONAL
2009-10-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Cardiac MRI to Predict Outcomes in Patients With STEMI
NCT07072858
A Prospective Multicenter Clinical Study on the Long-term Prognosis of Patients With ST-segment Elevation Myocardial Infarction Using Cardiac Magnetic Resonance Imaging.
NCT07057492
PET MRI in Coronary Artery Disease
NCT03451448
Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)
NCT02092428
Evaluation of the Factors Affecting the Diagnostic Performance of Coronary Computed Tomography Angiogram (CTA) With Multi-slice Computed Tomography (MSCT)
NCT01164839
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 272 patients will be prospectively enrolled from 8 cities in China.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sinus rhythm
Exclusion Criteria
* Acute coronary syndrome
* Atria fibrillation
* Coronary stents
* Bypass grafts
* Renal insufficiency (estimated glomerular filtration rate assessed by creatinine clearance \<60 ml/min/1.73 m2)
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fujian Medical University Union Hospital
OTHER
Air Force Military Medical University, China
OTHER
Huazhong University of Science and Technology
OTHER
Nanjing Medical University
OTHER
First Affiliated Hospital, Sun Yat-Sen University
OTHER
Henan Provincial People's Hospital
OTHER
Fudan University
OTHER
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Radiology department of Xuanwu Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
kuncheng li, M.D.
Role: PRINCIPAL_INVESTIGATOR
Xuanwu Hospital, Beijing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Radiology Department of Xuanwu Hopital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yang Q, Li K, Liu X, Bi X, Liu Z, An J, Zhang A, Jerecic R, Li D. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0-T: a comparative study with X-ray angiography in a single center. J Am Coll Cardiol. 2009 Jun 30;54(1):69-76. doi: 10.1016/j.jacc.2009.03.016.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CapitalMedicalU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.